Trials / Recruiting
RecruitingNCT07452614
Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker
Efficacy of Metabolic Biomarkers in Predicting Twelve-Month Outcomes of Vital Pulp Treatment in Symptomatic Teeth With Carious Pulp Exposure: A Controlled Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Abeer Ghalib Abdul-khaliq · Academic / Other
- Sex
- All
- Age
- 16 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This prospective controlled clinical trial investigates whether metabolic biomarkers measured in pulpal blood at the time of carious pulp exposure can predict the 12-month outcomes of vital pulp treatment in symptomatic permanent teeth. Eligible patients aged 16-50 years presenting with deep carious pulp exposure will undergo vital pulp therapy (partial pulpotomy or full pulpotomy). Pulpal blood samples will be collected at the time of exposure and analyzed using High-Performance Liquid Chromatography (HPLC). Treatment outcomes will be assessed clinically and radiographically at 12 months. The study aims to identify objective, measurable biomarkers that can improve pulpal diagnosis and guide clinical decision-making in vital pulp therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | vital pulp treatment | Vital pulp treatment (VPT) is defined by the European Society of Endodontology as a group of biologically based procedures aimed at preserving the health and function of the dental pulp that has been exposed or is at risk of exposure. These procedures involve removal of infected or inflamed tissue where necessary, protection of the remaining vital pulp with a biocompatible material, and placement of a definitive restoration to achieve a hermetic seal and support healing. |
Timeline
- Start date
- 2026-02-20
- Primary completion
- 2028-06-01
- Completion
- 2028-10-01
- First posted
- 2026-03-05
- Last updated
- 2026-04-01
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT07452614. Inclusion in this directory is not an endorsement.